As we found that maspin gene expression was strongly linked to ERα expression status, we quantified maspin mRNA expression in a well-defined cohort of 105 ERα-positive postmenopausal breast cancer patients who were treated with primary surgery, followed by adjuvant tamoxifen alone and whose long-term outcome was known. The gene discussed is SERPINB5; the disease is breast carcinoma.